P
Peter W.F. Wilson
Researcher at Emory University
Publications - 736
Citations - 150278
Peter W.F. Wilson is an academic researcher from Emory University. The author has contributed to research in topics: Framingham Heart Study & Framingham Risk Score. The author has an hindex of 181, co-authored 680 publications receiving 139852 citations. Previous affiliations of Peter W.F. Wilson include Tufts Medical Center & Memorial University of Newfoundland.
Papers
More filters
Journal ArticleDOI
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry
Michael G. Nanna,Ann Marie Navar,Pearl Zakroysky,Qun Xiang,Anne C. Goldberg,Jennifer G. Robinson,Véronique L. Roger,Salim S. Virani,Peter W.F. Wilson,Peter W.F. Wilson,Joseph Elassal,L. Veronica Lee,Tracy Y. Wang,Eric D. Peterson +13 more
TL;DR: Demographic, clinical, socioeconomic, belief-related, and clinician differences contributed to observed differences and represent potential targets for intervention.
Journal ArticleDOI
Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells
Erik L. Bao,Satish K. Nandakumar,Satish K. Nandakumar,Satish K. Nandakumar,Xiaotian Liao,Xiaotian Liao,Xiaotian Liao,Alexander G. Bick,Juha Karjalainen,Marcin Tabaka,Olga I. Gan,Olga I. Gan,Aki S. Havulinna,Tuomo Kiiskinen,Caleb A. Lareau,Aitzkoa Lopez de Lapuente Portilla,Bo Li,Bo Li,Connor A. Emdin,Connor A. Emdin,Veryan Codd,Veryan Codd,Christopher P. Nelson,Christopher P. Nelson,Christopher J. Walker,Claire Churchhouse,Albert de la Chapelle,Daryl E. Klein,Björn Nilsson,Björn Nilsson,Peter W.F. Wilson,Peter W.F. Wilson,Kelly Cho,Kelly Cho,Saiju Pyarajan,J. Michael Gaziano,J. Michael Gaziano,Nilesh J. Samani,Nilesh J. Samani,Aviv Regev,Aviv Regev,Aviv Regev,Aarno Palotie,Aarno Palotie,Benjamin M. Neale,John E. Dick,John E. Dick,Pradeep Natarajan,Pradeep Natarajan,Christopher J. O'Donnell,Mark J. Daly,Mark J. Daly,Michael Milyavsky,Sekar Kathiresan,Sekar Kathiresan,Vijay G. Sankaran +55 more
TL;DR: A large-scale genome-wide association study identifies 17 genetic loci that are associated with the risk of myeloproliferative neoplasms (MPNs), and shows that the modulation of haematopoietic stem cell function drives MPN risk.
Journal ArticleDOI
Gallin; an antimicrobial peptide member of a new avian defensin family, the ovodefensins, has been subject to recent gene duplication
Daoqing Gong,Daoqing Gong,Peter W.F. Wilson,Maureen M. Bain,Karina McDade,Jiri Kalina,Virginie Hervé-Grépinet,Yves Nys,Ian C. Dunn +8 more
TL;DR: The relatively recent evolution of multiple forms of a member of a new defensin related group of peptides that are termed ovodefensins, may be an adaptation to increase expression or the first steps in divergent evolution of the gene in chickens.
Journal ArticleDOI
Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program.
Jacklyn N. Hellwege,Jacklyn N. Hellwege,Digna R. Velez Edwards,Digna R. Velez Edwards,Ayush Giri,Ayush Giri,Chengxiang Qiu,Jihwan Park,Eric S. Torstenson,Eric S. Torstenson,Jacob M. Keaton,Jacob M. Keaton,Otis D. Wilson,Cassianne Robinson-Cohen,Cecilia P. Chung,Cecilia P. Chung,Christianne L. Roumie,Christianne L. Roumie,Derek Klarin,Scott M. Damrauer,Scott M. Damrauer,Scott L. DuVall,Edward D. Siew,Elvis A. Akwo,Matthias Wuttke,Mathias Gorski,Mathias Gorski,Man Li,Yong Li,J. Michael Gaziano,J. Michael Gaziano,J. Michael Gaziano,Peter W.F. Wilson,Peter W.F. Wilson,Philip S. Tsao,Philip S. Tsao,Christopher J. O'Donnell,Csaba P. Kovesdy,Csaba P. Kovesdy,Cristian Pattaro,Anna Köttgen,Anna Köttgen,Katalin Susztak,Todd L. Edwards,Todd L. Edwards,Adriana M. Hung,Adriana M. Hung +46 more
TL;DR: The authors reinterpret the genetic architecture of kidney function across ancestries, to identify not only genes, but the tissue and anatomical contexts of renal homeostasis and the clinical consequences of dysregulation.
Journal ArticleDOI
Tracking of glycated hemoglobin in the original cohort of the framingham heart study
TL;DR: It is concluded that glycated hemoglobin reliably categorizes the glucose control of nondiabetic subjects over a period of 4 to 6 years, confirming its value as an epidemiological measure.